Supplementary materialS Cell lines
Human foreskin fibroblast (HFF) cells and TOV112D cells were sourced from the American Type Culture Collection (ATCC). HFF cells were cultured in DMEM media containing 10% FBS. The TOV112D is an endometriod cell cancer cell line [1] , and was cultured in RPMI media supplemented with 10% FBS, 1% L-glutamine and 1% sodium pyruvate. IGROV1 is a mixed ovarian cancer cell line [2, 3] and was purchased as part of the NCI60 cell line panel from Charles River Laboratories, and were cultured in were cultured in RPMI media containing 10% FBS and1% l-glutamine. MCF10A WT parental and MCF10A P53-/-cells were purchased from Horizon Discovery and were cultured in DMEM/F-12 including 2.5 mM L-glutamine and 15 mM HEPES, supplemented with 5% horse serum, 10 µg/mL insulin, 20 ng/mL hEGF, 0.5 µg/mL hydrocortisone, 0.1 µg/mL cholera toxin. MDA-MB-436-EV and MDA-MB-436 -BRCA1 (Ms N Buckley, Queens University Belfast, UK) were generated by transfecting the BRCA1-mutant MDA-MB-436 cells with either empty vector pcDNA3.1 or pcDNA3.1-BRCA1, followed by selection in 300 μg/mL G418, and were maintained in 50:50 ratio of RPMI-1640 and Leibovitz's L-15 medium supplemented with 10% fetal calf serum containing 300 μg/ml G418. All cell lines were routinely tested for mycoplasma contamination. Stable shRNA mediated knockdown of SRC in TOV112D cells was performed by lentivirus infection, using the ViraPower™ Lentiviral Expression Systems (Life Technologies). Briefly, HEK293FT cells were transfected with 3 μg of shRNA DNA (Sigma), along 9 μg of ViraPower™ Packaging Mix using Lipofectamine 2000 (Life technologies) according to manufacturers guidelines. 72 hours post transfection, virus particles were collected. To infect TOV112D cells, virus particles were diluted 1:5 in full TOV112D growth medium, and supplemented with 5 μg/ml polybrene (Millipore). 72 hours post infection, media was removed from TOV112D cells and replaced with normal growth media containing 0.5 μg/ml puromycin. SRC knockdown clones were isolated by dilution cloning; once cells reached confluency they were trypsinized and resuspended in 10 mls of growth media and 5μl of the cell suspension was plated into a 15 cm plate. A number of colonies were picked and expanded, and knockdown of SRC was confirmed by western blotting.
sirna screening
Human foreskin fibroblast cells were reverse transfected with the siRNA library (Qiagen) using Lipofectamine RNAiMax reagent as per manufacturer's instructions (Life Technologies). Cells were transfected with 10 nM siRNA. 24 hours later media was changed to normal growth media containing either DMSO or 10 μM saracatinib, and 72 hours later cell viability was assayed using the Cell Titre Glo assay (Promega). The sensitivity of the screen was monitored by PLK1 siRNA causing a reduction in viability of more than 90%, when compared to transfection with a non-targeting siRNA control (All-stars). The siRNA screen was performed once and the average robust z-scores of the 3 independent siRNAs targeting each gene was determined for each cell line. 
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Supplementary table 1: sirna target genes (tumour suppressor genes or genes whose loss has been implicated in cancer development). See Supplementary_Table_1
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